Package 51672-1393-1

{"route": ["ORAL"], "spl_id": "440646d8-f538-5968-e063-6394a90ab7cd", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["VZI5B1W380"], "rxcui": ["283536"], "spl_set_id": ["9d5ba8a3-d1ea-4d5b-aafd-3a7ba2d4746c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, GLASS in 1 CARTON (51672-1393-1)  / 250 mL in 1 BOTTLE, GLASS", "package_ndc": "51672-1393-1", "marketing_start_date": "20250806"}], "brand_name": "OXCARBAZEPINE", "product_id": "51672-1393_440646d8-f538-5968-e063-6394a90ab7cd", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51672-1393", "generic_name": "OXCARBAZEPINE", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXCARBAZEPINE", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "60 mg/mL"}], "application_number": "ANDA078734", "marketing_category": "ANDA", "marketing_start_date": "20250806", "listing_expiration_date": "20261231"}